ONCORAL PHARMA ApS: Financial statements 2016
CVR: 35481214
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
ONCORAL PHARMA ApS (CVR 35481214) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -419,209 and a net result of DKK -934,525 compared with DKK -1,046,198 the year before. Equity in the 2016 report amounted to DKK -4,516,776.
- Gross Profit
- DKK -419,209
- Profit/Loss
- DKK -934,525
- Equity
- DKK -4,516,776
- Total Assets
- DKK 1,470,264
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -419 t. | -935 t. | -4.5 mio. | 0 |
| 2015 | - | -997 t. | -1 mio. | -3.6 mio. | 0 |
Official annual report
Find more companies like ONCORAL PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
ONCORAL PHARMA ApS has published its annual report for 2015. Gross profit came to DKK -997,161, and the net result was DKK -1,046,198.
About ONCORAL PHARMA ApS
ONCORAL PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2013. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Magnus Olafsson Corfitzen. The company is owned by Ascelia Pharma AB. The company has 0 employees (2014). In 2025, the company reported a gross profit of DKK -1,617,542 and a net result of DKK -2,313,169 compared with DKK -4,057,834 the year before. Equity in the 2025 report amounted to DKK -35,503,290.